Brief Report| Volume 21, ISSUE 2, P277-280.e3, February 2020

A Randomized Trial of Alerting to Low Glycated Hemoglobin Level in Older Adults: Results of the Low Indexes of Metabolism Intervention Trial B (LIMIT-B)

Published:October 03, 2019DOI:



      The benefit of alerting clinical staff to low plasma glycated hemoglobin (HbA1c) in patients aged 75 years and older who receive antidiabetic drugs remains uncertain.

      Design, Setting, and Participants

      In a randomized controlled trial, 1684 patients with HbA1c ≤ 6.5% who received antidiabetic drugs were assigned to have an e-mail alert sent to their physician, and 1643 were assigned to have no such alert (control group). The primary outcome of the trial was annual death. Secondary outcomes included antidiabetic drug dose reduction and HbA1c change.


      In the first quarter, antidiabetic drug-defined daily doses were reduced on average by 10.4 ± 35.8 (16% ± 55%) in the intervention group and by 6.4 ± 36.1 (10% ± 56%) in the control group (difference −4.1 ± 1.2, 95% confidence interval [CI] −6.5 to −1.6; P = .001). Measured HbA1c levels were raised by a mean (± standard deviation) of 0.28 ± 0.77 in the intervention group and by 0.18 ± 0.57 in the control group (difference 0.10 ± 0.02, 95% CI –0.15 to −0.059, P < .001). One year after the alerts, 121 patients (7.2%) died in the intervention group and 107 patients (6.5%) died in the control group (relative risk 1.1, 95% CI 0.86-1.42; P = .44).

      Conclusions and Implications

      In this trial, alerting clinical staff to low HbA1c in patients aged 75 years and older treated with antidiabetic medicines was associated with mildly reduced antidiabetic doses and increased HbA1c but was not associated with a significant difference in survival rate compared with usual clinical care.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Abdelhafiz A.H.
        • Rodriguez-Manas L.
        • Morley J.E.
        • et al.
        Hypoglycemia in older people—A less well recognized risk factor for frailty.
        Aging Dis. 2015; 6: 156-167
        • Kezerle L.
        • Shalev L.
        • Barski L.
        Treating the elderly diabetic patient: Special considerations.
        Diabetes Metab Syndr Obes. 2014; 7: 391-400
        • Sugimoto T.
        • Ono R.
        • Kimura A.
        • et al.
        Impact of glycemic control on daily living activities over 1-year follow-up in memory clinic patients with diabetes.
        J Am Med Dir Assoc. 2019; 20: 792-794
        • Boussageon R.
        • Supper I.
        • Bejan-Angoulvant T.
        • et al.
        Reappraisal of metformin efficacy in the treatment of type 2 diabetes: A meta-analysis of randomised controlled trials.
        PLoS Med. 2012; 9: e1001204
        • Griffin S.J.
        • Leaver J.K.
        • Irving G.J.
        Impact of metformin on cardiovascular disease: A meta-analysis of randomised trials among people with type 2 diabetes.
        Diabetologia. 2017; 60: 1620-1629
        • Currie C.J.
        • Peters J.R.
        • Tynan A.
        • et al.
        Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study.
        Lancet. 2010; 375: 481-489
        • Ismail-Beigi F.
        • Craven T.
        • Banerji M.A.
        • et al.
        Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial.
        Lancet. 2010; 376: 419-430
        • Lipska K.J.
        • Ross J.S.
        • Miao Y.
        • et al.
        Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
        JAMA Intern Med. 2015; 175: 356-362
        • Farrell B.
        • Black C.
        • Thompson W.
        • et al.
        Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.
        Can Fam Physician. 2017; 63: 832-843
        • Garfinkel D.
        • Mangin D.
        Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: Addressing polypharmacy.
        Arch Intern Med. 2010; 170: 1648-1654
        • Dills H.
        • Shah K.
        • Messinger-Rapport B.
        • et al.
        Deprescribing medications for chronic diseases management in primary care settings: A systematic review of randomized controlled trials.
        J Am Med Dir Assoc. 2018; 19: 923-935.e2
        • Herrin J.
        • da Graca B.
        • Nicewander D.
        • et al.
        The effectiveness of implementing an electronic health record on diabetes care and outcomes.
        Health Serv Res. 2012; 47: 1522-1540
        • Weber V.
        • Bloom F.
        • Pierdon S.
        • et al.
        Employing the electronic health record to improve diabetes care: A multifaceted intervention in an integrated delivery system.
        J Gen Intern Med. 2008; 23: 379-382
        • Shane-McWhorter L.
        • Lenert L.
        • Petersen M.
        • et al.
        The Utah Remote Monitoring Project: Improving health care one patient at a time.
        Diabetes Technol Ther. 2014; 16: 653-660
        • Tsabar N.
        • Press Y.
        • Rotman J.
        • et al.
        The Low Indexes of Metabolism Intervention Trial (LIMIT): Design and baseline data of a randomized controlled clinical trial to evaluate how alerting primary care teams to low metabolic values, could affect the health of patients aged 75 or older.
        BMC Health Serv Res. 2018; 18: 4
        • Press Y.
        • Punchik B.
        • Kagan E.
        • et al.
        Which factors affect the implementation of geriatric recommendations by primary care physicians?.
        Isr J Health Policy Res. 2017; 6: 7
        • Sleath J.D.
        In pursuit of normoglycaemia: The overtreatment of type 2 diabetes in general practice.
        Br J Gen Pract. 2015; 65: 334-335
        • McCoy R.G.
        • Van Houten H.K.
        • Ross J.S.
        • et al.
        HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001-13: Observational population based study.
        BMJ. 2015; 351: h6138